Publications
Richard, A.M., Wong, N.R., Harris, K., Sundar, R., Scott, E.E., and Pochapsky, T.C.
(2023)
An approach to selective steroidogenic cytochrome P450 haem iron ligation by steroid-derived isonitriles
Commun. Chem.
in press.
Burris-Hiday, Scott, E.E.
(2023)
Allosteric Modulation of Cytochrome P450 Enzymes by the NADPH Cytochrome P450 Reductase FMN-containing domain
J. Biol. Chem.
in press.
Liu,J., Kandel, S.E., Lampe, J.N., and Scott, E.E.
(2023)
Human cytochrome P450 3A7 binding four copies of Its native substrate dehydroepiandrosterone 3-sulfate
J. Biol. Chem.
in press.
Burris-Hiday, S.D., Loomis, C.L., Richard, A.M., Scott, E.E.
(2023)
Generation of human steroidogenic cytochrome P450 enzymes for structural and functional characterization
Meth. Enzymol.
in press.
Liu, J., Offei, S.D., Yoshimoto, F.K., Scott, E.E.
(2023)
Pyridine-containing substrate analogs are restricted from accessing the human cytochrome P450 8B1 active site by tryptophan 281
J. Biol. Chem.
299:103032.
Petrunak, E.M., Bart, A.G., Peng, H-W., Auchus, R.J., and Scott, E.E.
(2023)
Human Cytochrome P450 17A1 Structures with Metabolites of Prostate Cancer Drug Abiraterone Reveal Substrate-Binding Plasticity and a Second Binding Site
J. Biol. Chem.
299(3):102999.
Roberts, A.G., Stevens, J.C., Szklarz, G.D., Scott, E.E., Kumar, S., Shah, M.B., and Halpert, J.R.
(2023)
Four decades of CYP2B research: from protein adducts to protein structures and beyond
Drug Metab. Dispos.
51:111-122.
Liu, J., Carlson, H.A., and Scott, E.E.
(2022)
Cytochrome P450 8B1 structure and function: supporting drug design for non-alcoholic fatty liver disease and diabetes
J. Biol. Chem.
298:102344. *Selected as Editor's Pick*.
Loomis, C.L., Brixius-Anderko, S., and Scott, E.E.
(2022)
Redox partner adrenodoxin alters cytochrome P450 11B1 ligand binding and inhibition
J. Inorg. Biochem.
235:111934.
Bart, A.G., Morais, G., Vangala, V.R., Loadman, P.M., Pors, K. and Scott, E.E.
(2022)
Cytochrome P450 binding and bioactivation of tumor-targeted duocarmycin agents
Drug Metab. Dispos.
50:49-57.
Vogt, C.D., Bart, A.G., Yadav, R., Scott, E.E. and Aubé, J.
(2021)
Effects of fluorine substitution on substrate conversion by cytochromes P450 17A1 and 21A2
Org. Biomol. Chem
19:7664-7669.
Brixius-Anderko, S. and Scott, E. E.
(2021)
Structural and functional insights into aldosterone synthase interaction with its redox partner protein adrenodoxin
J. Biol. Chem.
296:100794.
Brixius-Anderko, S. and Scott, E. E.
(2021)
Aldosterone synthase structure with Cushing’s Disease drug LCI699 highlights avenues for selective CYP11B drug design
Hypertension
78:751-759.
Burris-Hiday, S.B. and Scott, E.E.
(2021)
Steroidogenic cytochrome P450 17A1 structure and function
Mol. Cell. Endocrinol.
528:11261.
Lu, J., Bart, A.G., Wu, Q., Criscione, K.R., McLeish, M.J., Scott, E.E., and Grunewald, G.L.
(2020)
Structure-based drug design of bisubstrate inhibitors of phenylethanolamine N‐Methyltransferase possessing low nanomolar affinity at both substrate binding domains
J. Med. Chem
63:13878-13898.
Wróbel, T. M., Rogova, O., Andersen, K. L., Yadav, R., Brixius-Anderko, S., Scott, E. E., Olsen, L., Jørgensen, F. S. and Björkling, F.
(2020)
Discovery of novel non-steroidal cytochrome P450 17A1 inhibitors as potential prostate cancer agents
Int. J. Mol. Sci.
21:4868-4879.
Russell, L.E., Schleiff, M.A., Gonzalez, E., Bart, A.G., Broccatelli, F., Durmus, S., Hartman, J.H., Humphreys, W.G., Lauschke, V.M., Martin, I., Nichols, C., Nwabufo, C., Prasad, B., Scott, E.E., Segall, M., Takahashi, R., Taub, M.E., and Sodhi, J..K.
(2020)
Advances in the study of drug metabolism
Drug Metab. Rev.
295:5640-5653.
Bart, A. G., Harris, K. L., Gillam E. M. J., and Scott, E. E.
(2020)
Structure of an ancestral mammalian family 1B1 cytochrome P450 with increased thermostability
J. Biol. Chem.
295:5640-5653.
van Rooyen, D., Yadav, R., Scott, E. E. and Swart, A. C.
(2020)
CYP17A1 exhibits 17α-hydroxylase/17,20-lyase activity towards 11β-hydroxy progesterone and 11-ketoprogesterone metabolites in the C11-oxy backdoor pathway
J. Steroid Biochem. Mol. Biol.
199:105614.
Bart A. G., Takahashi R. H., Wang X., Scott E. E.
(2019)
Human cytochrome P450 1A1 adapts active site for atypical nonplanar substrate
Drug Metab. Dispos.
48: 86-92.
Brixius-Anderko, S. and Scott, E. E.
(2019)
Structure of human cortisol-producing cytochrome P450 11B1 bound to the breast cancer drug fadrozole provides insights for drug design
J. Biol. Chem.
294: 453-460.
Bart, A. G. and Scott, E. E.
(2018)
Structures of human cytochrome P450 1A1 with bergamottin and erlotinib
J. Biol. Chem.
293:19201-19210.
Yadav, R. and Scott, E. E.
(2018)
Endogenous insertion of non-native metalloporphyrins into human membrane cytochrome P450 enzymes
J. Biol. Chem.
293:16623-16634.
Scott, E. E. and Godamudunage, M. P. (2018) Structures of Human Cytochrome P450 Enzymes: Variations on a Theme
(2018)
Dioxygen-dependent Heme Enzymes
Eds. Ikeda-Saito and Raven. Publisher, Royal Society of Chemistry
.
Godamudunage, M. P., Grech, A. M. and Scott, E. E.
(2018)
Comparison of antifungal azole interactions with adult cytochrome P450 3A4 vs. neonatal cytochrome P450 3A7
Drug Metab. Dispos.
46:1329-1337.
Fehl, C., Vogt, C., Yadav, R. Li, K., Scott, E. E. and Aubé, J.
(2018)
Structure-based design of inhibitors with improved selectivity for steroidogenic cytochrome P450 17A1 over cytochrome P450 21A2
J. Med. Chem
11:4946-4960.
Bart, A.G. and Scott, E.E.
(2017)
Structural and functional effects of cytochrome b5 interactions with human cytochrome P450 enzymes
J. Biol. Chem.
20818-20833.
Petrunak, E.M., Rogers, S.A., Aubé, J., and Scott, E.E.
(2017)
Structural and functional evaluation of clinically relevant inhibitors of cytochrome P450 17A1 (CYP17A1)
Drug Metab. Dispos.
635-645.
Scott, E.E.
(2017)
Omega versus omega-1 hydroxylation: Cytochrome P450 4B1 sterics make the call
J. Biol. Chem.
292:5622-5623.
Li, A., Yadav, R., White, J.K., Herroon, M.K., Callahan, B.P., Podgorski, I., Turro, C., Scott, E.E., and Kodanko, J.J.
(2017)
Illuminating cytochrome P450 binding: Ru (II)-caged inhibitors of CYP17A1
Commun. Chem.
53:3673-3676.
Yadav, R., Petrunak, E.M., Estrada, D.F., and Scott, E.E.
(2016)
Structural insights into the function of steroidogenic cytochrome P450 17A1
Mol. Cell. Endocrinol.
7207:30330-30336.
Bonomo, S., Hansen, C.H., Petrunak, E.M., Scott, E.E., Styrishave, B., Jorgensen, F. S., and Olsen, L.
(2016)
Promising tools in prostate cancer research: Selective non steroidal cytochrome P450 17A1 inhibitors
Nat. Sci. Reports
6:29468-29479.
Scott, E.E., Wolf, R.C., Otyepka, M., Humphreys, S.C., Reed, J.R., Henderson, C.J., McLaughlin, L.A., Paloncýová, M., Navrátilová, V., Berka, K., Anzenbacher, P., Dahal, U.P. Barnaba, C., Brozik, J.A., Jones, J.P., Estrada, D.F., Laurence, J.S., Park, J.W., and Backes, W.L.
(2016)
The role of protein-protein and protein-membrane interactions on P450 function
Drug Metab. Dispos.
44:576-590.
Estrada, D.F., Laurence, J.S., and Scott, E.E.
(2015)
Cytochrome P450 17A1 interactions with the FMN domain of its reductase as characterized by NMR
J. Biol. Chem.
291:3390-4003.
Petrunak, E.M., DeVore, N.M., Porubsky, P.R. and Scott, E.E.
(2014)
Structures of human steroidogenic cytochrome P450 17A1 with substrates
J. Biol. Chem.
289:32952-32964.
Estrada, D.F., Skinner, A.L., Laurence, J.S., and Scott, E.E.
(2014)
Human cytochrome P450 conformational selection: Modulation by ligand and cytochrome b5
J. Biol. Chem.
289:14310-14320.
Johnson, E.F., Connick, J.P., Reed, J.R., Backes, W.L., Desai, M.C., Xu, L., Estrada, D.F., Laurence, J.S. and Scott, E.E.
(2014)
Correlating structure and function of drug metabolizing enzymes: progress and ongoing challenges
Drug Metab. Dispos.
42:9-22.
Walsh, A.A., Szklarz, G.D. and Scott, E.E.
(2013)
Human cytochrome P450 1A1 structure and utility in understanding drug and xenobiotic metabolism
J. Biol. Chem.
288:12932-12943.
Blake, L.C., Roy, A., Neul, D., Schoenen, F.J., Aubé, J. and Scott, E.E.
(2013)
Benzylmorpholine analogs as selective inhibitors of lung cytochrome P450 2A13 for the chemoprevention of lung cancer in tobacco users
Pharm. Res.
30:2290-2302.
Estrada, D.F., Laurence, J.S., and Scott, E.E.
(2013)
Substrate-modulated cytochrome P450 17A1 and cytochrome b5 interactions revealed by NMR
J. Biol. Chem.
288:17008-17018.
Stephens, E.S., Walsh, A.A., and Scott, E.E.
(2012)
Evaluation of inhibition selectivity for human cytochrome P450 2A enzymes
Drug Metab. Dispos.
40:1797-802.
DeVore, N.M. and Scott, E.E.
(2012)
Cytochrome P450 17A1 structures with prostate cancer drugs abiraterone and TOK-001
Nature
482:116-119.
DeVore, N.M. and Scott, E.E.
(2012)
Nicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) binding and access channel in human cytochrome P450 2A6 and 2A13 enzymes
J. Biol. Chem.
287:26576-26585.
DeVore, N.M., Meneely, K.M., Bart, A.G., Stephens, E.S., Battaile, K.P., and Scott, E.E.
(2012)
Structural comparison of cytochromes P450 2A6, 2A13, and 2E1 with pilocarpine
FEBS J.
279:1621-31 .
Reed, T., Lushington, G.H., Xia, Y., Hirakawa, H., Mure, M., Scott, E.E., and Limburg, J.
(2010)
Crystal structure of histamine dehydrogenase from Nocardioides simplex
J. Biol. Chem.
285:25782-25791.
Porubsky, P.R., Battaile, K.P., and Scott, E.E.
(2010)
Human cytochrome P450 2E1 structures with fatty acid analogs reveal a previously unobserved binding mode
J. Biol. Chem.
285:22282-22290.
Swanson, H.I., Njar, V.C.O., Yu, Z., Castro, D.J., Gonzalez, F.J., Williams, D.E., Huang, Y., Kong, A-N.T., Doloff, J.C., Ma, J., Waxman, D.J., and Scott, E.E.
(2010)
Targeting drug metabolizing enzymes for effective chemoprevention and chemotherapy
Drug Metab. Dispos.
38:539-544.
Culpepper, M.A., Scott, E.E., and Limburg, J.
(2010)
Crystal structure of prolyl 4-hydroxylase from Bacillus anthracis
Biochemistry
49:124-133.
DeVore, N.M., Smith, B.D., Wang, J.L., Lushington, G.H., and Scott, E.E.
(2009)
Key residues controlling binding of diverse ligands to human cytochrome P450 2A Enzymes
Drug Metab. Dispos.
37:1319-1327.
Porubsky, P.R., Meneely, K.M., and Scott, E.E.
(2008)
Structures of human cytochrome P450 2E1: Insights into the binding of inhibitors and both small molecular weight and fatty acid substrates
J. Biol. Chem.
283:33698-33707.
DeVore, N.M., Smith, B.D., Urban, M.J., and Scott, E.E.
(2008)
Key residues controlling phenacetin metabolism by human cytochrome P450 2A enzymes
Drug Metab. Dispos.
36:2582-2590.
Miller, M.A., Scott, E.E., and Limberg, J.
(2008)
Expression, purification, crystallization and preliminary X-ray studies of a proly-4-hydroxylase protein from Bacillus anthracis
Acta Crystallogr. F.
64:788-791.
Reed, T.M., Hirakawa, H., Mure, M., Scott, E.E., and Limberg, J.
(2008)
Expression, purification and crystallization and preliminary X-ray studies of histamine dehydrogenase from Nocardiodes simplex
Acta Crystallogr. F.
64:785-787.
Porubsky, P.R., Scott, E.E., and Williams, T.D.
(2008)
p-Dimethylaminocinnamaldehyde derivatization for colorimetric detection and HPLC-UV/Vis-MS/MS identification of indoles
Arch. Biochem. Biophys.
475:14-17.
Schlicht, K.E., Michno, N., Smith, B.D., Scott, E.E., and Murphy, S.E.
(2007)
Functional characterization of CYP2A13 polymorphisms
Xenobiotica
37:1439-1349.
Smith B.D., Sanders J.L., Porubsky P.R., Lushington G.H., Stout C.D., and Scott, E.E.
(2007)
Structure of the human lung cytochrome P450 2A13
J. Biol. Chem.
282:17306-17313.
Scott E.E. and Halpert J.R.
(2005)
Structures of cytochrome P450 3A4
Trends in Biochem. Sci.
30:5-7.